StockMarketWire.com - Biotherapeutics company PureTech Health said founded entity and oncology company Vor Biopharma had appointed Matthew R Patterson to its board.
Patterson was co-founder of Audentes Therapeutics and was its chief executive for eight years until its acquisition by Astellas Pharma in 2020.
At 1:23pm: [LON:PRTC] Puretech Health PLC share price was -8.5p at 241.5p
Story provided by StockMarketWire.com
Shares Magazine
Shares is the leading weekly publication for retail investors. It is packed with investment ideas, news and educational material to help build and run portfolios and get more from your money.
Investor Events
Shares puts on free Investor Events throughout the year across the country. They provide an opportunity for investors to learn more about companies on the stock market and hear from a range of investment experts including fund managers and Shares journalists.